ESTÍBALIZ
PÉREZ GUZMÁN
Hospital de Cruces
Barakaldo, EspañaPublications in collaboration with researchers from Hospital de Cruces (2)
2021
-
Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial
The Lancet, Vol. 398, Núm. 10295, pp. 121-130
2015
-
Provision of Care by Medical Residents and the Impact on Quality
Archivos de Bronconeumologia, Vol. 51, Núm. 10, pp. 515-519